Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay

Keyphrases

• Immunoassay 100%
• Breast Cancer 100%
• AKT1 100%
• Nanofluidics 100%
• Akt Isoforms 100%
• Patient Response 66%
• Drug Response 66%
• Protein Isoforms 66%
• Variable Roles 33%
• Tumor 33%
• Clinical Trials 33%
• Patient Assessment 33%
• Specific Antibodies 33%
• Breast Cancer Cells 33%
• Akt Phosphorylation 33%
• Breast 33%
• Targeted Intervention 33%
• Fully Automated 33%
• Total Protein 33%
• Subtype-specific 33%
• Protein Molecules 33%
• Prognostic Biomarker 33%
• Isoelectric Point 33%
• Cancer-related 33%
• Tumorigenesis 33%
• Detection Accuracy 33%
• Drug Target 33%
• Multiple Cancers 33%
• Nanocapillary 33%
• Differentially Phosphorylated Protein 33%
• Electrophoresis 33%
• Accurate Evaluation 33%
• Molecular Variation 33%
• Pan-specific 33%
• Breast Cancer Subtypes 33%
• Highly Sensitive Assay 33%
• Clinical Specimens 33%

Biochemistry, Genetics and Molecular Biology

• Isoform 100%
• Immunoassay 100%
• Protein Isoform 40%
• AKT1 40%
• Cancer Cell 20%
• Clinical Trial 20%
• Phosphoprotein 20%
• Drug Targeting 20%
• Carcinogenesis 20%
• Quantitative Technique 20%
• Protein 20%
• Drug Response 20%
• Antibodies 20%
• Electrophoresis 20%
• Isoelectric Point 20%